Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 20.52 USD 0.93% Market Closed
Market Cap: 13B USD

EV/OCF
Enterprise Value to OCF

-1 550.2
Current
36.6
Median
4.4
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-1 550.2
=
Enterprise Value
84B DKK
/
Operating Cash Flow
-54.2m DKK
Market Cap EV/OCF
DK
Genmab A/S
NASDAQ:GMAB
87.1B USD -1 550.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -219 794.4
US
Abbvie Inc
NYSE:ABBV
321.1B USD 23.3
US
Amgen Inc
NASDAQ:AMGN
145.9B USD 15.7
US
Gilead Sciences Inc
NASDAQ:GILD
134.1B USD 14.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.9B USD -107.9
US
Epizyme Inc
F:EPE
94.1B EUR -512.2
AU
CSL Ltd
ASX:CSL
119.6B AUD 28.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
65.4B USD 15.1
US
Seagen Inc
F:SGT
39.3B EUR -80.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
38.1B USD -809.6
 
DK
Genmab A/S
NASDAQ:GMAB
Average EV/OCF: 19.4
Negative Multiple: -1 550.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 794.4
US
Abbvie Inc
NYSE:ABBV
23.3
US
Amgen Inc
NASDAQ:AMGN
15.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -107.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -512.2
AU
CSL Ltd
ASX:CSL
28.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -80.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -809.6

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A